Log In
Print this Print this

nadolol (INV102)

  Manage Alerts
Collapse Summary General Information
Company Invion Ltd.
DescriptionAdrenergic receptor beta (ADRB) antagonist
Molecular Target Adrenergic receptor beta (ADRB)
Mechanism of ActionAdrenergic receptor beta (ADRB) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAsthma
Indication DetailsTreat mild asthma
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today